Preclinical liver toxicity models: Advantages, limitations and recommendations-Reference-Cited by-同舟云学术

Preclinical liver toxicity models: Advantages, limitations and recommendations

Published:2025-02 Issue: Volume:511 Page:154020
ISSN:0300-483X
Container-title:Toxicology
language:en
Short-container-title:Toxicology

Author:

Ezhilarasan Devaraj,Karthikeyan Sivanesan,Najimi Mustapha,Vijayalakshmi Paramasivan,Bhavani Ganapathy,Jansi Rani Muthukrishnan

Publisher

Elsevier BV

Reference175 articles.

1. Melatonin mitigated methotrexate-induced hepatotoxicity through interrelated biological processes;Abdallah;Mol. Biol. Rep.,2024

2. Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen;Abdel-Dayem;Drugs R. D.,2014

3. Protective effects of crocin against methotrexate-induced hepatotoxicity in adult male albino rats: histological, immunohistochemical, and biochemical study;AbdelKader;Cureus,2023

4. Influence of resveratrol on liver fibrosis induced by dimethylnitrosamine in male rats;Abdu;Saudi J. Biol. Sci.,2019

5. Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients;Abe;Biol. Open,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGF2 Mediated USP42‐PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration;Advanced Science;2025-03-17

2. Exploring ethanol’s toxicity in the oral submucosa: chronic exposure versus abstinence in C57BL/6 mice;Xenobiotica;2025-03-16

3. Four years after the ranitidine withdrawal by FDA: Is it time for India to act?;Drug Discovery Today;2025-01